Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Regulatory & Legal

TITLE:

NMA: EMA press release on the final preparations for launching the new EudraVigilance system on 22 November 2017.

BRIEF:

The new system will benefit from improved reporting and analysis of Suspected Adverse Events in order to ensure better monitoring of the safety of medicines and streamlining the reporting process by stakeholders.

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company